SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Current antibiotic and prophylactic antifungal drug policies in UK neonatal intensive care units: a national survey

Kantyka, C; Wanigasekara, R; Ponnusamy, V; Heath, PT; Clarke, P (2025) Current antibiotic and prophylactic antifungal drug policies in UK neonatal intensive care units: a national survey. JAC-Antimicrobial Resistance, 7 (5). dlaf194. ISSN 2632-1823 https://doi.org/10.1093/jacamr/dlaf194
SGUL Authors: Heath, Paul Trafford

[img] PDF Published Version
Available under License Creative Commons Attribution.

Download (253kB)

Abstract

Objectives To survey the current antibiotic and antifungal drug practices of UK neonatal intensive care units (NICUs), and to identify antibiotic preferences and policies for treatment of early- and late-onset sepsis (EoS and LoS), meningitis, and antifungal prophylaxis. Methods Between January and May 2024, we contacted all 53 tertiary-level UK NICUs via telephone and/or e-mail. We requested a copy of each unit’s guidelines for antibiotic treatment of EoS and LoS, and antifungal prophylaxis. Results We obtained guidelines from 53/53 (100%) units. A penicillin and aminoglycoside combination was the consistent first-line recommendation for EoS in 51/53 (96%) units. Only a minority (11/53; 21%) units specified any second-line antibiotic regimen for EoS, though most (44/53; 83%) specifically recommended amoxicillin for suspected listeriosis. For LoS, almost all NICUs (52/53; 98%) provided specific guidance on empirical first-line antibiotic treatment, with empirical narrow-spectrum antibiotics as first-line LoS treatment for term neonates in 42/53 (79%) NICUs and for preterm neonates in 41/53 (77%) NICUs. Fifty-four percent (29/53) of units included specific LoS recommendations for neonates with indwelling central venous catheters. Sixty-six percent (35/53) of NICUs included cefotaxime in their empirical meningitis regimens. Eighty-five percent (45/53) of units had clear guidelines for antifungal prophylaxis. Conclusions While EoS treatment was consistent across units, there remained wide variation in antibiotic regimens used for LoS and meningitis, and for neonates with indwelling central venous catheters. Guidelines specific to preterm neonates were limited. The practice of routine antifungal prophylaxis has been more prevalent since the last UK survey in 2006–07 but is still neither universal nor consistent.

Item Type: Article
Additional Information: © The Author(s) 2025. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: JAC-Antimicrobial Resistance
ISSN: 2632-1823
Language: en
Related URLs:
Publisher License: Creative Commons: Attribution 4.0
Dates:
Date Event
2025-10-16 Published
2025-09-22 Accepted
URI: https://openaccess.sgul.ac.uk/id/eprint/118027
Publisher's version: https://doi.org/10.1093/jacamr/dlaf194

Actions (login required)

Edit Item Edit Item